Pharma Mar S.A. (MC:PHM) — Stock Price

€80.90 EUR
▲ 3.19% today

Pharma Mar S.A. (MC:PHM) is currently trading at €80.90 EUR, up 3.19% today. Over the past 52 weeks, shares have ranged between €67.00 and €103.60. This page tracks Pharma Mar S.A.'s live share price on the MC exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see how much is Pharma Mar S.A. worth.

Pharma Mar S.A. (PHM) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Pharma Mar S.A.'s daily closing share price and trading volume on the MC exchange over the past year, giving a clear view of recent price momentum and liquidity.

Pharma Mar S.A. Income Statement — Revenue, Profit & Earnings by Year

Pharma Mar S.A.'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue €221.39 Million €174.85 Million €158.15 Million €196.34 Million €229.83 Million
Cost of Revenue €12.26 Million €8.18 Million €9.61 Million €13.64 Million €16.44 Million
Gross Profit €209.13 Million €166.67 Million €148.54 Million €182.70 Million €213.39 Million
Research & Development €95.19 Million €103.50 Million €99.30 Million €83.45 Million €72.17 Million
SG&A €2.14 Million €2.85 Million €18.26 Million €19.02 Million €17.37 Million
Total Operating Expenses €168.85 Million €160.20 Million €152.37 Million €138.27 Million €121.04 Million
Operating Income €40.28 Million €6.47 Million €-3.83 Million €44.07 Million €92.45 Million
EBITDA €48.30 Million €21.23 Million €4.55 Million €52.07 Million €104.08 Million
EBIT €40.28 Million €14.45 Million €-1.21 Million €46.17 Million €98.50 Million
Interest Expense €1.06 Million €2.47 Million €2.42 Million €2.38 Million €3.37 Million
Income Before Tax €59.65 Million €11.98 Million €-3.62 Million €43.79 Million €95.13 Million
Income Tax Expense €-15.34 Million €-14.14 Million €-4.76 Million €-5.57 Million €2.27 Million
Net Income €74.99 Million €26.12 Million €1.14 Million €49.36 Million €92.86 Million

Pharma Mar S.A. Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Pharma Mar S.A.'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets €395.08 Million €349.64 Million €340.52 Million €393.26 Million €368.39 Million
Total Current Assets €283.42 Million €250.25 Million €252.60 Million €275.18 Million €295.23 Million
Cash & Equivalents €28.13 Million
Short-term Investments €149.41 Million €91.29 Million €102.54 Million €32.61 Million €88.53 Million
Net Receivables €60.59 Million €34.68 Million €27.55 Million €29.32 Million €78.91 Million
Inventory €54.10 Million €50.89 Million €39.29 Million €27.75 Million €10.54 Million
Property, Plant & Equipment €34.72 Million €26.90 Million
Goodwill
Total Liabilities €143.25 Million €141.28 Million €147.08 Million €170.30 Million €190.47 Million
Total Current Liabilities €93.88 Million €82.69 Million €95.89 Million €97.32 Million €86.35 Million
Long-term Debt €35.55 Million €39.87 Million €27.04 Million €25.88 Million €33.39 Million
Net Debt €31.60 Million €-12.16 Million €-16.36 Million €-107.18 Million €-64.02 Million
Total Stockholder Equity €251.83 Million €208.36 Million €193.44 Million €222.96 Million €177.92 Million
Retained Earnings €233.82 Million €168.38 Million €142.22 Million €156.51 Million €121.29 Million

Pharma Mar S.A. Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Pharma Mar S.A. generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow €53.13 Million €6.03 Million €-13.45 Million €38.32 Million €25.68 Million
Capital Expenditures €9.38 Million €15.51 Million €15.96 Million €8.85 Million €7.80 Million
Free Cash Flow €43.75 Million €-9.48 Million €-29.40 Million €29.47 Million €17.87 Million
Investing Cash Flow €-60.79 Million €1.03 Million €-43.05 Million €10.88 Million €18.47 Million
Financing Cash Flow €-36.52 Million €-5.35 Million €-32.14 Million €-13.37 Million €-27.41 Million
Dividends Paid €13.95 Million €11.42 Million €11.69 Million €11.76 Million €10.87 Million
Stock-Based Compensation €320.00K €0.00 €297.00K €393.00K €339.00K
Depreciation €8.02 Million €6.77 Million €5.76 Million €5.90 Million €5.58 Million
Change in Cash €-45.42 Million €3.21 Million €-89.79 Million €36.47 Million €17.14 Million

Pharma Mar S.A. Earnings History — EPS Actual vs. Analyst Estimates

Track Pharma Mar S.A.'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 23, 2026 0.13
Mar 05, 2026 3.42 2.37 +44.20%
Oct 30, 2025 -0.24 -0.15 -56.80%
Jul 30, 2025 1.33 0.03 +4332.33%
Apr 24, 2025 -0.22 0.18 -222.22%
Feb 26, 2025 1.06 -0.14 +859.36%
Oct 29, 2024 0.21 -0.09 +347.06%
Jul 30, 2024 0.07 -0.15 +146.67%